photo of Dr Holly Voges

Dr Holly Voges

Dr Holly Voges

Details

Role Team Leader / Senior Research Officer
Research area Stem Cell Medicine

Contact

Available for student supervision
Dr Voges is a Team Leader in the Heart Regeneration group at the Murdoch Children’s Research Institute (MCRI). Her research focuses on the generation of novel pluripotent stem cell-based models of the human heart and the utility of these models to understand heart development, maturation, and disease progression.

She obtained her PhD from the University of Queensland in 2019 and subsequently undertook postdoctoral training in high throughput phenotypic screening and disease modelling. In 2023, Dr Voges joined Professor Porrello’s laboratory at MCRI where she leads a research program focused around generating heart valve tissues from human pluripotent stem cells to study heart valve development and disease.

Dr Voges has received more than $2M in competitive research funding and has been recognized with multiple awards and distinctions, including the Rising Star Award from the Australasian Society for Stem Cell Research (2024) and Shirley E. Freeman Award for Innovation from the National Heart Foundation (2022). She is also passionate about equity in STEM and has been involved in MCRI’s Science Australia Gender Equity (SAGE) Athena Swan Bronze Accreditation (2021 – 2024) as a working group chair and was a member of the gender equity committee from 2021-2023.
Dr Voges is a Team Leader in the Heart Regeneration group at the Murdoch Children’s Research Institute (MCRI). Her research focuses on the generation of novel pluripotent stem cell-based models of the human heart and the utility of these models to...
Dr Voges is a Team Leader in the Heart Regeneration group at the Murdoch Children’s Research Institute (MCRI). Her research focuses on the generation of novel pluripotent stem cell-based models of the human heart and the utility of these models to understand heart development, maturation, and disease progression.

She obtained her PhD from the University of Queensland in 2019 and subsequently undertook postdoctoral training in high throughput phenotypic screening and disease modelling. In 2023, Dr Voges joined Professor Porrello’s laboratory at MCRI where she leads a research program focused around generating heart valve tissues from human pluripotent stem cells to study heart valve development and disease.

Dr Voges has received more than $2M in competitive research funding and has been recognized with multiple awards and distinctions, including the Rising Star Award from the Australasian Society for Stem Cell Research (2024) and Shirley E. Freeman Award for Innovation from the National Heart Foundation (2022). She is also passionate about equity in STEM and has been involved in MCRI’s Science Australia Gender Equity (SAGE) Athena Swan Bronze Accreditation (2021 – 2024) as a working group chair and was a member of the gender equity committee from 2021-2023.

Top Publications

  • Yeow, S, Frost, H, Porrello, ER, Steer, A, Voges, HK. Valve biology and rheumatic heart disease pathogenesis.. Nat Cardiovasc Res 2026
    view publication
  • Chung, JD, Trieu, J, Parker, BL, Nguyen, JH, Chee, A, Chan, AS, Jayasimhan, A, Deliyanti, D, Houweling, PJ, Voges, HK, et al. Intrinsic muscle stem cell dysfunction underlies functional deficits in models of type 1 diabetes.. NPJ Regen Med 11(1) : 8 2026
    view publication
  • Pocock, M, Reid, JD, Robinson, HR, Charitakis, N, Krycer, JR, Foster, SR, Fitzsimmons, RL, Lor, M, Tuano, N, Howden, S, et al. Maturation of human cardiac organoids enables complex disease modelling and drug discovery. 2026
    view publication
  • Nucera, Charitakis, N, Leung, R, Leichter, A, Tuano, N, Walkiewicz, M, Sawant, V, Rowley, L, Scurr, M, Er, P, et al. Application of spatial transcriptomics across organoids: a high-resolution spatial whole-transcriptome benchmarking dataset. 2026
    view publication
  • Pocock, MW, Reid, JD, Robinson, HR, Charitakis, N, Krycer, JR, Foster, SR, Fitzsimmons, RL, Lor, M, Devilée, LAC, Batho, CAP, et al. Maturation of human cardiac organoids enables complex disease modeling and drug discovery.. Nat Cardiovasc Res 4(7) : 821 -840 2025
    view publication

Page 1 of 7

Career information